News
Citing recent orders in other courts, a Johnson & Johnson subsidiary sought on Tuesday to reopen its 2023 lawsuit against ...
Hosted on MSN1y
Johnson & Johnson Wants To Deal With Talc Lawsuit Overhang, Proposes $6.5B Settlement PackageWednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ovarian cancer arising from cosmetic talc ...
A Johnson & Johnson unit holding talc-related asbestos liabilities moved to file an updated lawsuit accusing a medical expert ...
American pharmaceutical giant Johnson & Johnson (JNJ) has once again faced rejection on its $10 billion plan to settle thousands of ...
A woman who says that asbestos in Johnson & Johnson products caused her incurable cancer was awarded $29 ... the jury sided with her. This lawsuit is one of over 13,000 that Johnson & Johnson ...
However, recent evidence has linked this talc-based product (and similar ones from other manufacturers) to ovarian cancer. In May 2020, Johnson & Johnson announced it would stop selling its legacy ...
Hosted on MSN5mon
Johnson & Johnson risks UK lawsuit over talc cancer claimUK claimants announced Wednesday legal action against US pharmaceutical and cosmetics giant Johnson & Johnson ... not associated with the risk of ovarian cancer nor mesothelioma".
Johnson & Johnson has signaled that it will attempt to disqualify certain plaintiffs' lawyers and use other aggressive ...
Johnson & Johnson has denied that its talc products contain asbestos and that asbestos-laced talc can cause ovarian ... lawsuit alleging a link between its talcum powder products and cancer.
This is the company’s third attempt to settle a lawsuit alleging that ... all women and talc-related ovarian cancer, we’ll be ready to meet them.” Johnson and Johnson announced in 2020 ...
Shares of Johnson & Johnson fell more than 5% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other ...
(RTTNews) - Johnson & Johnson (JNJ ... over 60,000 claims from individuals alleging its baby powder caused ovarian cancer. Following the ruling, JNJ's stock fell to $157.11, moving it about ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results